2011
DOI: 10.1016/j.acra.2010.08.023
|View full text |Cite
|
Sign up to set email alerts
|

Idiopathic Parkinson Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
1

Year Published

2014
2014
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 25 publications
1
8
1
Order By: Relevance
“…These changes observed in gray matter are highly consistent with the results of previous studies that investigated the effects of intervention on MD (Abe et al 2014 ; Razek et al 2011 ; Sagi et al 2012 ). Furthermore, two of these studies reported an increase in MD in the gray matter (Abe et al 2014 ; Razek et al 2011 ). As described above, changes in synapse or synaptic vesicles, astrocytes, dendritic sprouting, and angiogenesis have been demonstrated or considered as the causes of these changes in MD.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…These changes observed in gray matter are highly consistent with the results of previous studies that investigated the effects of intervention on MD (Abe et al 2014 ; Razek et al 2011 ; Sagi et al 2012 ). Furthermore, two of these studies reported an increase in MD in the gray matter (Abe et al 2014 ; Razek et al 2011 ). As described above, changes in synapse or synaptic vesicles, astrocytes, dendritic sprouting, and angiogenesis have been demonstrated or considered as the causes of these changes in MD.…”
Section: Discussionsupporting
confidence: 91%
“…MDDS has been shown to be more accurate in dissociating the pathology of dopaminergic systems than PET measures of dopamine receptor binding (Seppi et al 2004 ). It can also detect the neural plasticity caused by medication with dopamine agonists to manage this pathology (Razek et al 2011 ). MDDS was also robustly associated with the motivational state and novelty seeking (Takeuchi and Kawashima 2013 ) which are strongly associated with the function of the dopaminergic system (Bódi et al 2009 ; Kaasinen et al 2004 ; Kaplan and Oudeyer 2007 ; Schinka et al 2002 ; Suhara et al 2001 ; Tomer and Aharon-Peretz 2004 ).…”
Section: Introductionmentioning
confidence: 99%
“…37 Further, an intervention study of Parkinson's disease revealed that administration of the dopamine agonist L-dopa led to increased MD in regions of the dopaminergic system. 14 Therefore, a greater amount of VGP and concomitant increase in dopamine release are associated with later MD changes in the dopaminergic system, akin to the effects of substances that release dopamine. The MD of these areas is associated with traits with negative affect, whereas excessive VGP is associated with emptiness or depressive tendencies when not playing videogames.…”
Section: Discussionmentioning
confidence: 99%
“…11, 12 In particular, MD in the dopaminergic system has been shown to be quite sensitive to pathological, pharmacological and cognitive differences or changes related to dopamine. 12, 13, 14, 15 On the other hand, FA is known to be relatively more strongly associated with microstructural properties related to brain connectivity and sensitive to increases in axonal membrane thickness, diameter and/or the amount of parallel organization of the axons and can also reflect the process of neural plasticity. 10, 16 We, therefore, utilized these measures in this study.…”
Section: Introductionmentioning
confidence: 99%
“…Previous study results are conflicting whether or not levadopa treatment would be of influence on changes in diffusivity of different brain structures. One study reported significant differences in putaminal ADC values between PD patients on levodopa treatment and matched untreated patients [ 52 ], and they suggested that these differences could be attributed to the use of levodopa. However, other studies found no effect of levodopa treatment on FA or ADC values [ 53 , 54 ].…”
Section: Discussionmentioning
confidence: 99%